Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Vulcan Infrastructure Director’s Award Represents About 77.5% of Resulting Holding

Vulcan Infrastructure & Power Inc. awarded director Rothschild Allan B. 38,251 shares at a zero price. The transaction was recorded on September 10, 2026.

Vinay Lochav | 15 September 2026

Woodside Energy Director Resigns Effective September 13 (NYSE: WDS)

Woodside Energy Group Ltd (NYSE: WDS) has lost non-executive director Mark Cutifani CBE, whose resignation took effect on 13 September 2026. Cutifani’s departure follows his decision to reassess his global professional commitments and where he can devote his time and personal contributions.

Vinay Lochav | 15 September 2026

Zapata Quantum Sets October 9 Virtual Annual Meeting

Zapata Quantum, Inc. (OTC: ZPTA) is asking stockholders to vote on six proposals at its 2026 annual meeting on October 9, including the election of directors and approval of reverse splits. The ballot also covers auditor ratification, say-on-pay, say-on-frequency and adjournment. The meeting will …

Vinay Lochav | 15 September 2026

Addus HomeCare (NASDAQ: ADUS) Agrees to $275M AccentCare Care Acquisition

Addus HomeCare Corp (NASDAQ: ADUS) agreed to acquire AccentCare’s personal care and community care business outside New York for $275,000,000 in cash. The purchase is subject to customary adjustments forWorking Capitaland other items. The agreement was dated September 12, 2026. Closing remains conditional on …

Vinay Lochav | 15 September 2026

Autonomix Medical (NASDAQ: AMIX) Sets October 29 Vote on Six Directors and Auditor

Autonomix Medical, Inc. (NASDAQ: AMIX) will ask shareholders to decide four proposals at its annual meeting on October 29, 2026. Shareholders of record as of September 8, 2026, are eligible to vote. Autonomix Medical had 1,959,938 issued and outstanding common shares entitled to vote …

Vinay Lochav | 15 September 2026

Biofrontera (NASDAQ: BFRI) Wins FDA Approval for 10% Ameluz Skin Cancer Use

Biofrontera Inc. (NASDAQ: BFRI) received FDA approval for its 10% Ameluz topical gel, used with the BF-RhodoLED lamp series to treat superficial basal cell carcinoma in adults. The approval makes Ameluz the first and only photodynamic therapy drug approved in the United States for …

Vinay Lochav | 15 September 2026

Bionano Genomics Presents OGM Opportunity Near $10B (NASDAQ: BNGO)

Bionano Genomics, Inc. (NASDAQ: BNGO) presented optical genome mapping alongside an estimated global total addressable market approaching $10B.

Vinay Lochav | 15 September 2026

Schjotz Gitte Receives 25 UL Solutions Derivative Securities

Schjotz Gitte received 25 derivative securities tied to UL Solutions across four transactions on September 10, 2026.

Vinay Lochav | 15 September 2026

Newsmax Inc. (NYSE: NMAX) 10% Owner Sells 24,736 Shares

Newsmax Inc. (NYSE: NMAX) shares were sold by Conyers Investments LLC in two transactions covering 24,736 shares.

Vinay Lochav | 15 September 2026

NOCOPI TECHNOLOGIES Awards 21,930 Shares to 10% Owner (OTC: NNUP)

NOCOPI TECHNOLOGIES INC/MD/ (OTC: NNUP) awarded 21,930 shares to FROST PHILLIP MD ET AL, identified as a 10% owner, on 11 September 2026. The shares were issued at $0 per share.

Vinay Lochav | 15 September 2026
Support

Hi! How can we help you today?

Loading…